Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

N0290

Sigma-Aldrich

Nitazoxanide

≥98% (HPLC)

Synonym(s):

NTZ; 2-(Acetyloxy)-N-(5-nitro-2-thiazolyl)benzamide

Sign Into View Organizational & Contract Pricing

Select a Size

10 MG
₪546.00
50 MG
₪1,942.00

₪546.00

Please contact Customer Service for Availability
Request a Bulk Order
All Photos(1)

Select a Size

Change View
10 MG
₪546.00
50 MG
₪1,942.00

About This Item

Empirical Formula (Hill Notation):
C12H9N3O5S
CAS Number:
55981-09-4
Molecular Weight:
307.28
EC Number:
259-931-8
MDL number:
MFCD00416599
UNSPSC Code:
12352200
PubChem Substance ID:
329818424
NACRES:
NA.77

₪546.00

Please contact Customer Service for Availability
Request a Bulk Order

Assay

≥98% (HPLC)

form

powder

originator

Romark

storage temp.

2-8°C

SMILES string

CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+]([O-])=O

InChI

1S/C12H9N3O5S/c1-7(16)20-9-5-3-2-4-8(9)11(17)14-12-13-6-10(21-12)15(18)19/h2-6H,1H3,(H,13,14,17)

InChI key

YQNQNVDNTFHQSW-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

Nitazoxanide (NTZ), a thiazolide compound[1] is a antiparasitic drug with structure similar to niclosamide.[2]

Application

Nitazoxanide has been used:
  • to test its anti-viral activity against chikungunya virus[3]
  • as an antiprotozoal agent to test its effect on cell viability in various cancer cell lines[4]
  • to test its effect on human cytomegalovirus (HCMV) infected human fibroblast HFF cells[5]

Biochem/physiol Actions

Nitazoxanide (NTZ) promotes autophagy by acting on kinase based signaling pathways[5] and acts on mammalian target of rapamycin complex 1 (mTORC1) in Mycobacteria.[2] It has anti-viral property and effectively halts entry and release of chikungunya virus in in vitro studies.[3] NTZ also inhibits Japanese encephalitis virus (JEV) infection in early stages and has the potential to treat other viral infections including dengue, hepatitis B (HBV), coronavirus and human immunodeficiency virus (HIV).[3] It has antineoplastic functionality and may induce apoptosis by promoting proto-oncogene c-Myc inhibition resulting in tumor suppression.[1]
Nitazoxanide is an inhibitor of pyruvate-ferredoxin oxidoreductase (PFOR); Antimicrobial recently found to kill both non-replicating and replicating mycobacteria.
Nitazoxanide is an inhibitor of pyruvate-ferredoxin oxidoreductase (PFOR); FDA approved anti-parasitic drug (2002). Recent work (C & EN Sept. 14, 2009, p. 28) highlights that NTZ kills non-replicating and replicating TB bacteria and no apparent resistance is detected.

Features and Benefits

This compound was developed by Romark. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000296365
0000296365
0000160660
0000114613

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Pathway-based drug repositioning for cancers: Computational prediction and experimental validation
Iwata M, et al.
Journal of Medicinal Chemistry, 61(21), 9583-9595 (2018)
G Esmat et al.
Liver international : official journal of the International Association for the Study of the Liver, 32 Suppl 1, 146-150 (2012-01-11)
Hepatitis C virus genotype 4 (HCV-4) is the most common type of hepatitis C virus (HCV) in the Middle East and Africa, in particular Egypt. Since the development of new protease inhibitors, the response of HCV-4 to the standard regimen
Andrew Hemphill et al.
Expert opinion on pharmacotherapy, 7(7), 953-964 (2006-04-26)
Colonisation of the gastrointestinal tract by anaerobic bacteria, protozoa, trematodes, cestodes and/or nematodes and other infectious pathogens, including viruses, represents a major cause of morbidity and mortality in Africa, South America and southeast Asia, as well as other parts of
Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission
Wang YM, et al.
Antiviral Research, 135, 81-90 (2016)
Olivier Vandenberg et al.
The Pediatric infectious disease journal, 31(1), 10-15 (2011-11-19)
Cryptosporidium outbreaks in day-care centers (DCCs) occur commonly. However, controlling spread of infection in these settings is difficult, and data about effectiveness of different control strategies are sparse. In this study, a Cryptosporidium outbreak in a large DCC located in
View All Related Papers

Articles

Bioactive Molecules for Immunology Research

Bioactive small molecules for immune system signaling target identification/validation and antibiotics, antivirals, and antifungals offered.

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service